Identification of continued challenges and opportunities in oncologists' comprehension of immuno-oncology

Herrmann, Tara; Pearce, Frieda; Warren, Charlotte E.; Kadkhoda, Haleh; Wiggins, Lianne; Rindo, Andrea

doi:10.1186/2051-1426-3-s2-p135

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…EM physicians are the first-line healthcare providers and they should be aware of immunotherapy-related adverse events to enable them to properly identify and manage these patients. Immediate recognition is critical for appropriate management [19][20][21]. This cross-sectional study aimed to assess and compare the level of scientific knowledge of immunotherapy toxicity and management in EM consultants and residents.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of Knowledge of Immunotherapy Toxicities Among Emergency Physicians in Riyadh, Saudi Arabia

Alahmadi¹,

Altamimi²,

Algarni³

2022

Cureus

View full text Add to dashboard Cite

IntroductionImmunotherapy is considered a new modality in the treatment of cancer with emerging different toxicity profiles. It is essential for healthcare practitioners to be aware of these side effects. Emergency medicine physicians are first-line health providers and should have the required knowledge and understanding of immunotherapy-related adverse effects to be able to identify and manage such patients. The study aimed to assess the level of knowledge of immunotherapy toxicity among emergency medicine physicians in Riyadh. MethodsThis cross-sectional study was conducted at the largest emergency medicine training centers in Riyadh. In total, 106 emergency medicine physicians participated. The questionnaire contained multiple-choice questions that assessed the knowledge and management of immunotherapy-related toxicities. ResultsThe majority of the participants were male residents. The response rate varied for the selected training centers. Regarding the level of knowledge regarding the toxic side effects of cancer immunotherapy, the majority were likely to choose "I don't know." ConclusionThis study, in support of the literature, revealed the gap in knowledge of the basic principles of cancer immunotherapy, despite increasing uses and indications of immunotherapy. The findings indicate the need for non-oncologist health practitioners, including emergency physicians, to enhance their knowledge of immunotherapy-related adverse events in order to improve their clinical decision-making skills.

show abstract

Section: Introductionmentioning

confidence: 99%

“…[20][21][22][23][24][25][26][27][28][29][30]-year age group. The sample was selected from the largest residency training centers in Riyadh, Saudi Arabia.…”

mentioning

confidence: 99%